Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.18 USD | +3.58% | +10.01% | -34.56% |
04-25 | Truist Securities Cuts Sage Therapeutics' Price Target to $18 From $22, Hold Rating Maintained | MT |
04-25 | Transcript : Sage Therapeutics, Inc., Q1 2024 Earnings Call, Apr 25, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-34.56% | 853M | |
-2.63% | 102B | |
+1.62% | 96.29B | |
+1.92% | 22.18B | |
-16.67% | 21.2B | |
-7.77% | 18.31B | |
-38.74% | 17.38B | |
-13.21% | 16.36B | |
+5.41% | 13.97B | |
+33.57% | 12.17B |
- Stock Market
- Equities
- SAGE Stock
- News Sage Therapeutics, Inc.
- Sage Therapeutics : Mizuho Downgrades Sage Therapeutics to Neutral from Buy, Sets $81 Price Target